JPA Health appoints Ogilvy, Edelman vet as COO
Michael Sloan joined the agency this month as chief operating officer.
Most recent articles by Alison Kanski
The Escalator: W2O names two board members
Plus people moves at Ashfield, Area 23 and Envision Pharma Group.
Fleishman, Havas Lynx health execs chosen to lead Cannes juries
FleishmanHillard’s Anne de Schweinitz and Havas Lynx’s Tom Richards have been named Pharma and Health & Wellness jury presidents.
Five things for pharma marketers to know: Thursday, December 5, 2019
Minnesota sues Juul over teen vaping; J&J says new tests found no asbestos in baby powder; Hospital groups challenge price transparency rule.
Five things for pharma marketers to know: Wednesday, December 4, 2019
Dr. Stephen Hahn’s FDA nomination advances; Alphabet CEO to step down; Local governments opting out of federal opioid lawsuit.
Open enrollment on pace amid ACA uncertainty
The healthcare law is facing court challenges, but enrollment is chugging on.
Policy Outlook 2020: Expect loads of talk, little action around biggest healthcare issues
A presidential election in 2020 means candidates and surrogates will be talking about healthcare, but the chances of meaningful change are slim.
Five things for pharma marketers to know: Wednesday, November 27, 2019
Federal prosecutors launch probe of opioid makers; Amazon rolls out medication reminders on Alexa; District of Columbia sues Juul for targeting teens.
UDG Healthcare buys Canale Communications
Canale will become part of Ashfield Healthcare Communications.
Five things for pharma marketers to know: Tuesday, November 26, 2019
Doctors turn to YouTube for surgical prep; Novartis to buy Medicines Company; PhRMA ends funding of addiction nonprofit Addiction Policy Forum.
